Antiproliferative activity of Humulus lupulus extracts on human hepatoma (Hep3B), colon (HT-29) cancer cells and proteases, tyrosinase, β-lactamase enzyme inhibition studies

References

• Kac J, Plazar J, Mlinarič A, et al. Antimutagenicity of hops (Humulus lupulus L.): bioassay-directed fractionation and isolation of xanthohumol. Phytomedicine 2008;15:216–20
   PubMed Web of Science ®Google Scholar
• Vogel S, Ohmayer S, Brunner G, et al. Natural and non-natural prenylated chalcones: synthesis, cytotoxicity and anti-oxidative activity. Bioorg Med Chem 2008;16:4286–93
   PubMed Web of Science ®Google Scholar
• Plazar J, Žegura B, Lah TT, et al. Protective effects of xanthohumol against the genotoxicity of benzo(a)pyrene (BaP), 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and tert-butyl hydroperoxide (t-BOOH) in HepG2 human hepatoma cells. Mutat Res 2007;632:1–8
   PubMed Web of Science ®Google Scholar
• Gao X, Deeb D, Liu Y, et al. Immunomodulatory activity of xanthohumol: inhibition of T cell proliferation, cell-mediated cytotoxicity and Th1 cytokine production through suppression of NF-κB. Immunopharmacol Immunotoxicol 2009;31:477–84
   PubMed Web of Science ®Google Scholar
• Stevens JF, Page JE. Xanthohumol and related prenylflavonoids from hops and beer: to your good health! Phytochemistry 2004;65:1317–30
   PubMed Web of Science ®Google Scholar
• Gerhäuser C. Beer constituents as potential cancer chemopreventive agents. Eur J Cancer 2005;41:1941–54
   PubMed Web of Science ®Google Scholar
• Colgate EC, Miranda CL, Stevens JF, et al. Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells. Cancer Lett 2007;246:201–9
   PubMed Web of Science ®Google Scholar
• Miranda CL, Stevens JF, Helmrich A, et al. Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food Chem Toxicol 1999;37:271–85
   PubMed Web of Science ®Google Scholar
• Delmulle L, Bellahcène A, Dhooge W, et al. Anti-proliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines. Phytomedicine 2006;13:732–4. (b) Delmulle L, Berghe VT, De Keukeleire D, et al. Treatment of PC-3 and DU145 prostate cancer cells by prenylflavonoids from hop (Humulus lupulus L.) induces a caspase independent form of cell death. Phytother Res 2008;22:197–203
   PubMed Web of Science ®Google Scholar
• Colgate EC, Miranda CL, Stevens JF, et al. Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells. Cancer Lett 2007;246:201–9
   PubMed Web of Science ®Google Scholar
• Albini A, Dell’Eva R, Venè R, et al. Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets. FASEB J 2006;20:527–9
   PubMed Web of Science ®Google Scholar
• Pan L, Becker H, Gerhäuser C. Xanthohumol induces apoptosis in cultured 40–16 human colon cancer cells by activation of the death receptor and mitochondrial pathway. Mol Nut Food Res 2005;49:837–43
   PubMed Web of Science ®Google Scholar
• Vanhoecke B, Derycke L, Van Marck V, et al. Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer. Int J Cancer 2005;117:889–95
   PubMed Web of Science ®Google Scholar
• Honma Y, Tobe H, Makishima M, et al. Induction of differentiation of myelogenous leukemia cells by humulone, a bitter in the hop. Leukemia Res 1998;22:605–10
   PubMed Web of Science ®Google Scholar
• Chen WJ, Lin JK. Mechanisms of cancer chemoprevention by hop bitter acids (beer aroma) through induction of apoptosis mediated by Fas and Caspase cascades. J Agric Food Chem 2004;52:55–64
   PubMed Web of Science ®Google Scholar
• Rahman A, Choudhary IM, Thomsen JW. Bioassay techniques for drug development. Holand: Harwood Academic Publishers; 2001:124–30, 136–8
   Google Scholar
• Zanoli P, Zavatti M. Pharmacognostic and pharmacological profile of Humulus lupulus L. J Ethnopharmacol 2008;116:383–96
   PubMed Web of Science ®Google Scholar
• Chang TM. Tyrosinase and tyrosinase inhibitors. J Biocatal Biotransform 2012;1:2
   Google Scholar
• Chang TS. An updated review of tyrosinase inhibitors. Int J Mol Sci 2009;10:2440–75
   PubMed Web of Science ®Google Scholar
• Madala PK, Tyndall JDA, Nall T, et al. Update 1 of: proteases universally recognize beta strands in their active sites. Chem Rev 2010;110:1–31
   PubMed Web of Science ®Google Scholar
• Önder FC, Ay M, Sarker SD. Comparative study of antioxidant properties and total phenolic content of the extracts of Humulus lupulus L. and quantification of bioactive components by LC−MS/MS and GC−MS. J Agric Food Chem 2013;61:10498−506
   PubMed Web of Science ®Google Scholar
• Braybrooke JP, Slade A, Deplanque G, et al. Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanoma. Clin Cancer Res 2005;11:1512–20
   PubMed Web of Science ®Google Scholar
• Dachs GU, Tupper J, Tozer GM. From bench to bedside for gene-directed enzyme prodrug therapy of cancer. Anti Cancer Drugs 2005;16:349–59
   PubMed Web of Science ®Google Scholar
• Alley MC, Scudiero DA, Monks A, et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988;48:589–601
   PubMed Web of Science ®Google Scholar
• Lee KR, Kozukue N, Han JS, et al. Glycoalkaloids and metabolites inhibit the growth of human colon (HT29) and liver (HepG2) cancer cells. J Agric Food Chem 2004;52:2832–9
   PubMed Web of Science ®Google Scholar
• Bournine L, Bensalem S, Wauters JN, et al. Identification and quantification of the main active anticancer alkaloids from the root of Glaucium flavum. Int J Mol Sci 2013;14:23533–44
   PubMed Web of Science ®Google Scholar
• Gerhäuser C, Alt AP, Klimo K, et al. Isolation and potential cancer chemopreventive activities of phenolic compounds of beer. Phytochem Rev 2002;1:369–77
   Google Scholar
• Lewis JC, Alderton G, Carson JF, et al. Lupulon and humulon-antibiotic constituents of hops. J Clin Invest 1949;28:916–19
   Web of Science ®Google Scholar
• Neve RA. Hops. 1st ed. London, New York: Chapman and Hall publishing Co.; 1991:201
   Google Scholar
• Verzele M, de Keukeleire D. Chemistry and analysis of hop and beer bitter acids. Amsterdam: Elsevier; 1991
   Google Scholar
• Witkop CJ. Albinism: hematologic-storage disease, susceptibility to skin cancer, and optic neuronal defects shared in all types of oculocutaneous and ocular albinism. Ala J Med Sci 1979;16:327–30
   PubMedGoogle Scholar
• Chadwick LR, Pauli GF, Farnsworth NR. The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties. Phytomedicine 2006;13:119–31
   PubMed Web of Science ®Google Scholar
• Masek A, Chrzescijanska E, Kosmalska A, et al. Characteristics of compounds in hops using cyclic voltammetry, UV–VIS, FTIR and GC–MS analysis. Food Chem 2014;156:353–61
   PubMed Web of Science ®Google Scholar
• Sarker SD, Latif Z, Gray AI. Natural product isolation. Methods in Biotechnology. 2nd ed. Totowa, New Jersey: Humana Press; 2006:1–23
   Google Scholar
• Sharma R. Enzyme inhibition: mechanisms and scope. In: Sharma R, ed. Enzyme inhibition and bioapplications. Rijeka, Croatia: InTech 2012:1–36
   Google Scholar